Sort   by:  
 Page size 
UnknownNovel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma.
Not available
S-EPMC7990054 | biostudies-literature
UnknownOutcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation.
Not available
S-EPMC7190439 | biostudies-literature
UnknownEffect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.
Not available
S-EPMC6445718 | biostudies-literature
UnknownCommunity health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
Not available
S-EPMC7855526 | biostudies-literature
UnknownCountry-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.
Not available
S-EPMC6146070 | biostudies-literature
UnknownHematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.
Not available
S-EPMC7572530 | biostudies-literature
UnknownRisk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.
Not available
S-EPMC8945306 | biostudies-literature
UnknownA degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis.
Not available
S-EPMC2746914 | biostudies-literature
UnknownOutcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.
Not available
S-EPMC8977261 | biostudies-literature
UnknownImpact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients.
Not available
S-EPMC10148918 | biostudies-literature
Sort   by:  
 Page size